The Cooper Companies, Inc. (NYSE:COO) Receives Consensus Rating of “Moderate Buy” from Analysts

The Cooper Companies, Inc. (NYSE:COOGet Rating) has received a consensus rating of “Moderate Buy” from the thirteen brokerages that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $382.60.

A number of analysts have issued reports on COO shares. Robert W. Baird boosted their target price on Cooper Companies from $371.00 to $385.00 in a research report on Friday. Mizuho increased their target price on shares of Cooper Companies from $385.00 to $390.00 in a report on Friday. JPMorgan Chase & Co. increased their price target on Cooper Companies from $300.00 to $330.00 in a research report on Monday, November 28th. Citigroup lifted their price objective on Cooper Companies from $348.00 to $368.00 and gave the company a “buy” rating in a research note on Monday, December 12th. Finally, Piper Sandler upped their target price on shares of Cooper Companies from $350.00 to $375.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 11th.

Cooper Companies Price Performance

Shares of NYSE COO opened at $351.81 on Monday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.20 and a quick ratio of 0.71. The firm’s 50 day simple moving average is $341.48 and its 200-day simple moving average is $310.44. Cooper Companies has a 12 month low of $244.21 and a 12 month high of $430.67. The stock has a market capitalization of $17.39 billion, a price-to-earnings ratio of 46.60, a PEG ratio of 2.56 and a beta of 0.89.

Cooper Companies (NYSE:COOGet Rating) last announced its quarterly earnings results on Thursday, March 2nd. The medical device company reported $2.90 earnings per share for the quarter, beating the consensus estimate of $2.66 by $0.24. The firm had revenue of $858.50 million during the quarter, compared to analyst estimates of $834.90 million. Cooper Companies had a return on equity of 8.47% and a net margin of 11.10%. Cooper Companies’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.24 EPS. Analysts expect that Cooper Companies will post 12.67 EPS for the current year.

Cooper Companies Announces Dividend

The business also recently announced a Semi-Annual dividend, which was paid on Friday, February 10th. Investors of record on Monday, January 23rd were given a $0.03 dividend. The ex-dividend date of this dividend was Friday, January 20th. Cooper Companies’s dividend payout ratio (DPR) is 0.79%.

Insider Activity at Cooper Companies

In other news, Director Jody S. Lindell sold 1,000 shares of the business’s stock in a transaction dated Friday, January 6th. The stock was sold at an average price of $344.30, for a total value of $344,300.00. Following the completion of the sale, the director now directly owns 13,543 shares of the company’s stock, valued at approximately $4,662,854.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is owned by corporate insiders.

Institutional Trading of Cooper Companies

A number of large investors have recently bought and sold shares of COO. Greenwood Capital Associates LLC acquired a new position in Cooper Companies in the 4th quarter valued at about $25,000. Belpointe Asset Management LLC acquired a new position in shares of Cooper Companies in the fourth quarter valued at approximately $30,000. Denali Advisors LLC purchased a new stake in shares of Cooper Companies during the fourth quarter worth approximately $33,000. CI Investments Inc. grew its position in Cooper Companies by 60.7% in the 3rd quarter. CI Investments Inc. now owns 135 shares of the medical device company’s stock valued at $36,000 after buying an additional 51 shares during the last quarter. Finally, Standard Family Office LLC purchased a new position in Cooper Companies in the 3rd quarter valued at $37,000. Institutional investors and hedge funds own 96.78% of the company’s stock.

About Cooper Companies

(Get Rating)

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.

See Also

Analyst Recommendations for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with's FREE daily email newsletter.